Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Pallàs M
inhibits oxidative phosphorylation and all the ATP-dependent processes occurring on the coupling membrane of mitochondria
normalizes NO-dependent endothelial function and reduces platelet activation in diabetic rats induced by Streptozocin
InChiKey: ZSBXGIUJOOQZMP-JLNYLFASSA-N
The compound appears to be an effective anti-migraine medication that is well tolerated and does not display the vasoconstrictive effect that precludes the use of triptans and dihydroergotamine in certain patients
Fenoldopam mesylate Size:Solid 2 mg Pallàs MFenoldopam mesylate is a synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. Fenoldopam is used as an antihypertensive agent. It was approved by the Food and Drug Administration (FDA) in September 1997. Since fenoldopam is the only intravenous agent that improves renal perfusion, in theory it could be beneficial in hypertensive patients with concomitant renal insufficiency. Product information CAS Number: 67227 57 0
US$ 897.50
US$ 677.00
US$ 1624.50
US$ 897.50